Genocea Biosciences Depreciation & Amortization 2011-2026 | GNCA

Annual Depreciation & Amortization Genocea Biosciences

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.56 M	1.14 M	1.1 M	1.09 M	1.52 M	1.81 M	1.05 M	469 K	318 K	300 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.81 M	300 K	1.03 M

Quarterly Depreciation & Amortization Genocea Biosciences

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	400 K	-	-	-	381 K	-	867 K	556 K	276 K	-	825 K	550 K	272 K	-	815 K	543 K	270 K	-	1.23 M	878 K	449 K	-	1.31 M	828 K	361 K	-	661 K	391 K	180 K	-	298 K	160 K	78 K	-	231 K	172 K	86 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.31 M	78 K	503 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Compugen Ltd. CGEN	461 K	$ 2.56	-6.41 %	$ 239 M	Israel
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Aptorum Group Limited APM	1.13 M	$ 0.89	1.48 %	$ 6.54 M	China
ACADIA Pharmaceuticals ACAD	920 K	$ 22.24	-1.9 %	$ 3.69 B	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
ImmuCell Corporation ICCC	2.78 M	$ 8.42	0.88 %	$ 76 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Innoviva INVA	26.3 M	$ 23.07	-2.62 %	$ 1.55 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Brainstorm Cell Therapeutics BCLI	199 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Jaguar Health JAGX	1.91 M	$ 0.23	-5.81 %	$ 536 K	USA
Aquestive Therapeutics AQST	548 K	$ 4.04	-1.34 %	$ 432 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 22.36	-3.99 %	$ 2.84 B	USA
KalVista Pharmaceuticals KALV	969 K	$ 26.71	38.8 %	$ 1.44 B	Britain
Autolus Therapeutics plc AUTL	8.3 M	$ 1.42	-4.39 %	$ 378 M	Britain
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.95	1.2 %	$ 4.86 M	Israel
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands